Steroid-responsive pancreatitides

doi:10.12998/wjcc.v8.i16.3411

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 8, Issue 16

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6440)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-3) series.

Item

Count

PDF

438

WORD

173

HTML

3401

Figures (1-3)

288

Tables (1-3)

282

Sum=4582

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

619

Download

1239

Sum=1858

Aug 26, 2020 (publication date) through Nov 7, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Cases. Aug 26, 2020; 8(16): 3411-3430
Published online Aug 26, 2020. doi: 10.12998/wjcc.v8.i16.3411

Table 2 Immune checkpoint inhibitors

Immune checkpoint inhibitors
Cytotoxic T lymphocyte antigen-4	Ipilimumab
Programmed death-1 inhibitor	Nivolumab, pembrolizumab
Programmed death ligand-1 inhibitor	Atezolizumab, avelumab, durvalumab

Citation: Pelaez-Luna M, Soriano-Rios A, Lira-Treviño AC, Uscanga-Domínguez L. Steroid-responsive pancreatitides. World J Clin Cases 2020; 8(16): 3411-3430
URL: https://www.wjgnet.com/2307-8960/full/v8/i16/3411.htm
DOI: https://dx.doi.org/10.12998/wjcc.v8.i16.3411